Why the Best NPs Read Outside Their Lane

NP CHRONICLES

Clinical Education for NP Students & New Graduates

Why the Best NPs Read Outside Their Lane

Career Development  |  Clinical Reasoning  |  Reflections on Practice

Ask any nurse practitioner how they spend their limited free time, and “reading medical journals for fun” probably isn't high on the list. Between clinical hours, charting, CE requirements, and whatever's left of a personal life, most of us protect our downtime fiercely. So when a colleague hands you an article, a book, or a podcast recommendation that has nothing to do with your specialty, the instinct to politely decline is understandable.

A recent Op-Med essay by psychiatrist Houston Paul Putman, MD, makes a case worth sitting with: that instinct, while protective, might be quietly working against us — not just as clinicians, but as people. Dr. Putman's reflection on reading outside his specialty offers something NPs in every practice setting can use, whether you're a new grad still finding your clinical voice or a seasoned provider who's settled into a comfortable routine.

The Trap of the Familiar Lane

Dr. Putman describes a common tension: he's happy to read articles friends and family send him about general health topics, and he welcomes colleagues' recommendations within psychiatry. But suggestions to read something entirely outside medicine — a novel, a history book, an unrelated nonfiction title — often feel like an intrusion on already-scarce time.

That instinct isn't unique to psychiatry. Nurse practitioners face the same pull toward narrowing focus. It's tempting, and often efficient, to read only what's directly relevant — the latest guideline update, a drug interaction alert, a case study in your exact patient population. Efficiency has its place. But Dr. Putman's essay raises a fair question: what does staying entirely in that lane cost us over time?

Heteroglossia and Why It Matters at the Bedside

The essay draws on a concept from literary theory: philosopher Mikhail Bakhtin's idea of “heteroglossia,” writing or thought that holds multiple voices and perspectives at once, as opposed to “monoglossia,” a single dominant, authoritative voice. Dr. Putman applies this directly to clinical practice: patients rarely hand us their most important information directly. It arrives sideways, in offhand comments, in what's left unsaid, in the way someone frames a complaint. Clinicians who've only ever practiced within one narrow intellectual register — medical literature and nothing else — may be less equipped to catch those indirect signals than clinicians who've spent time absorbing a wider range of human experience through fiction, history, or unrelated fields.

For NPs, this has an obvious parallel. A patient who mentions their sleep is “fine” in the same breath as a flat, exhausted affect. A teenager who answers every HEADSS question correctly but won't make eye contact. A caregiver whose answers about “how are you managing” get shorter every visit. Catching those cues isn't purely a function of clinical training — it's also a function of how broadly we've learned to read people, context, and subtext. Dr. Putman's argument is that reading widely trains exactly that muscle.

CLINICAL BOTTOM LINE Clinical expertise built entirely within a single specialty's literature can become a silo. Reading and engaging outside your specialty — medical or not — broadens the range of perspectives and communication patterns you recognize, which can sharpen your ability to pick up on what patients aren't saying directly. This isn't a replacement for clinical CE; it's a complementary habit that supports the “soft skills” side of assessment and rapport.

Why This Resonates for NPs Specifically

Nurse practitioners are, by training and by role, already accustomed to moving across boundaries. Many of us trained in nursing before moving into advanced practice, which means we've already had to translate between two professional languages — the nursing model of holistic, patient-centered care and the medical model of diagnosis and management. That background arguably makes the case for intellectual cross-pollination even stronger, not weaker: it's already part of how we're taught to think.

•     NPs frequently work across multiple specialties within a single day, especially in primary care, urgent care, or rural practice — which means a habit of reading broadly may pay off faster and more often than it would for a narrowly subspecialized physician.

•     The therapeutic relationship in NP practice is often built on time and rapport as much as on diagnostic precision. Anything that improves how well we read a patient's unspoken cues has a direct line to better adherence and outcomes.

•     New graduates in particular are often told to “just focus on clinical knowledge” in the first year. Dr. Putman's essay is a useful counterpoint: clinical knowledge and the capacity to understand people are not competing priorities, and neither has to wait for the other.

A caveat worth naming

NUANCE TO FLAG None of this is a substitute for staying current in your own specialty. Dr. Putman is explicit that he still prioritizes articles colleagues flag within psychiatry — he's simply arguing against treating everything outside that lane as automatically disposable. For NPs balancing CE requirements, certification maintenance, and clinical currency, reading outside your specialty is a supplement to core competency, not a replacement for it. If your CE hours or guideline review are behind, that comes first.

Practical Ways to Build the Habit

Dr. Putman's own solution wasn't to overhaul his schedule — it was to loosen his grip on how tightly he protected his reading time, and to start carrying a notebook to capture ideas that cross-pollinated from unrelated material into his clinical work. A few low-friction ways to try this yourself:

•     Say yes to one non-clinical recommendation a month from a colleague, friend, or patient — treat it as data about how other people think, not homework.

•     Attend a lecture or seminar outside health care once a quarter, even virtually. Dr. Putman specifically mentions university talks on physics, political science, and history as sources of unexpected clinical insight.

•     Keep a running note (paper or digital) of ideas or phrases from outside reading that unexpectedly connect to a patient encounter or a teaching point — you won't always see the value immediately, and that's fine.

•     Extend the same principle to journal clubs: occasionally read outside your specialty's literature, not just outside medicine altogether. A psychiatry NP reading a cardiology paper, or a family NP reading a palliative care piece, gets a version of the same benefit.

The Bigger Point

Dr. Putman's essay isn't really about reading logistics. It's about resisting what he calls the “narrowing mindset of expertise” — the quiet pull toward believing that depth in one area is best protected by walling off everything else. For NPs building a career, especially early on, that pull can feel like discipline. Dr. Putman's reflection suggests it might sometimes be the opposite: a limitation dressed up as focus.

As his own mentor once told him, “You can't take people farther than you've been yourself.” For clinicians whose job is fundamentally about understanding other people well enough to help them, that's a reasonable standard to hold ourselves to — in the exam room and in what we choose to read when we finally get a quiet hour to ourselves.

 

Reference

Putman, H.P. (2026, July 16). The importance of readin

Melanotan II: The Grey-Market Tanning Peptide Your Patients Aren't Telling You About

 

NP CHRONICLES Clinical Education for NP Students & New Graduates

 

Melanotan II: The Grey-Market Tanning Peptide Your Patients Aren't Telling You About

What NPs Need to Know About the “Barbie Drug” Circulating on Social Media

Clinical Pharmacology  |  Patient Safety  |  Social Media & Health Literacy

 

Your patient probably won't bring it up first. It might come up as an incidental question about a strangely even, persistent tan, or a nasal spray they mention almost in passing, or a young man in your urgent care with a priapism you can't immediately explain. Melanotan II is a self-administered, unregulated peptide being sold and promoted across social media as a sunless tanning shortcut, and most clinicians have never heard the name. It's worth changing that.

What Melanotan II Actually Is

Melanotan II is a synthetic analog originally developed in 1980s research at the University of Arizona, in a legitimate search for a way to protect fair skin from UV-driven cancer by stimulating melanin production without sun exposure. The compound that resulted binds melanocortin receptors broadly, and that's the problem: those same receptors also govern sexual arousal and appetite. One melanocortin pathway effect was potent enough that it was later developed into its own FDA-approved treatment for low libido — an indirect but real pharmacologic legacy of the same receptor family.

What's sold online today as “melanotan” is not a single, standardized product. The name covers more than one distinct synthetic compound, multiple formulations, and product vials of uncertain and sometimes mislabeled content, sold as injectable solution or nasal spray without a prescription, dosing standard, or manufacturing oversight.

Who Is Actually Using It

The stereotype — a young woman chasing an Instagram-ready glow — doesn't match the data. A small 2025 interview study of self-reported users found an average age around 39, with more than three-quarters male, and many describing initial exposure through gym and bodybuilding circles well before any social media tanning trend existed. The current “Barbie drug” branding may be driving new, younger users to a product with a longer and different history than the marketing suggests — which matters when you're taking a history and deciding whether to ask about it at all.

The Clinical Risk Worth Knowing By Name

A published case involved a man in his 40s who purchased melanotan over the counter from a supplement retailer and developed priapism — a painful, sustained erection requiring emergency drainage of blood from the penis and pharmacologic treatment to resolve. His erectile function had not fully recovered a month later. Reported adverse effects associated with melanotan use also include nausea, flushing, and case reports linking use to melanoma and renal injury; regulatory and dermatology sources have flagged all of these as reasons for caution.

One detail from qualitative interview data is worth sitting with clinically: some users interpreted nausea and flushing not as a red flag, but as reassurance the product was “working.” That reframes the counseling task — it isn't only about disclosing risk, it's about correcting an expectation that side effects are proof of efficacy.

Why This Keeps Circulating Despite Warnings

Fewer than one in five social media posts about melanotan even disclose that the product is unregulated, and posts referencing skin cancer disproportionately misrepresent the drug as protective rather than as a melanoma risk factor — a distortion of real 1980s research findings, repackaged for a modern audience the original scientists never anticipated. Enforcement has struggled to keep pace: one U.S. manufacturer's false cancer-protection claim took regulators roughly nine years to fully prosecute, ending in a felony conviction, while today the same claim circulates across countless anonymous social accounts with no single identifiable seller to hold accountable.

⬜ CLINICAL BOTTOM LINE Melanotan II is an unregulated, self-injected or intranasal melanocortin agonist sold online as a tanning aid, with case-reported links to priapism, and postmarketing signals for melanoma and renal injury. It is not FDA-approved for any indication. Because patients rarely volunteer use of grey-market peptides, consider a direct, nonjudgmental screening question in patients presenting with unexplained tanning, priapism, new pigmented lesions, or unexplained renal findings — particularly in patients with a bodybuilding or fitness-community background, not only those who fit the “influencer audience” stereotype.

 

🔴 CASE FROM PRACTICE A 41-year-old man presents to urgent care with a rigid, painful erection lasting several hours. He initially denies substance use. On further nonjudgmental questioning, he discloses a recent self-administered injection purchased from a supplement store, describing it only as “a tanning shot.” Approach: Recognize this presentation as a urologic emergency (ischemic priapism) requiring immediate referral for aspiration/irrigation and possible intracavernosal phenylephrine, regardless of the causative agent. Take a specific, low-judgment substance history that includes peptides and “tanning injections” by name, since patients may not recognize these as drugs requiring disclosure. Document the exposure and counsel on discontinuation and the unregulated nature of the product once the acute event is managed.

 

⚠️ NUANCE TO WATCH FOR Don't anchor your index of suspicion on the “young woman chasing a tan” stereotype the product's nickname implies. Available user data skews toward men in their late 30s with a fitness or bodybuilding background who may be using melanotan for its appetite and libido effects as much as for tanning — a very different risk profile and counseling conversation than the one the branding suggests.

 

Board Prep: Test Yourself

A patient presents with a persistent, deep tan out of proportion to reported sun exposure, along with new-onset priapism. Which class of self-administered compound should be on your differential, and why?

A) Topical retinoids — they can cause hyperpigmentation but have no effect on erectile physiology.

B) Melanocortin receptor agonists (e.g., melanotan II) — they stimulate melanogenesis and, through the same receptor family, can trigger priapism as a documented adverse effect.

C) Oral tanning supplements (canthaxanthin) — associated with skin discoloration but not vasoactive effects.

D) Topical DHA self-tanners — cosmetic only, no systemic receptor activity.

Answer: B. Melanocortin receptor agonists act on the same receptor family responsible for both melanogenesis and sexual arousal pathways, which explains why a tanning product can present with a urologic emergency. Because these products are sold outside regulated channels, patients often don't recognize — or disclose — that a “tanning injection” is a pharmacologically active drug.

 

References

Nevski, J. “The Barbie Drug Your Dermatologist Has Never Heard Of.” Student Contributor piece on melanotan II pharmacology, adverse events, and social media promotion, 2 July 2026.

NP Chronicles — supporting NP students and new graduates since 2012.

Autism and Vaccines: What NP Students and New NPs Need to Know Right Now

 

NP CHRONICLES

Clinical Education for NP Students & New Graduates

CLINICAL PRACTICE & PATIENT COMMUNICATION

Autism and Vaccines: What NP Students and New NPs Need to Know Right Now

If you've seen headlines this fall about the CDC “changing its position” on vaccines and autism, you're not imagining it — and your patients have seen those headlines too. This post walks through what actually changed, what the scientific evidence still shows, and how to talk with families about it with confidence.

What Happened on the CDC Website

On November 19, 2025, the CDC quietly rewrote its “Autism and Vaccines” webpage. The prior version stated plainly that studies show no link between vaccination and autism spectrum disorder (ASD). The revised page instead says the claim “vaccines do not cause autism” is “not an evidence-based claim,” argues that studies have not fully “ruled out” a link, and asserts that research supporting a link has been “ignored by health authorities.” The change reflects positions long promoted by HHS Secretary Robert F. Kennedy Jr. and President Trump, despite being contrary to the existing scientific evidence.

The header “Vaccines do not cause autism” is still technically on the page — but it now carries an asterisk explaining it wasn't removed because the evidence supports keeping it, but because of a prior agreement with Senator Bill Cassidy, chair of the Senate HELP Committee.

The reaction from the scientific and medical community was fast and pointed. Public health experts described the change as anti-science and warned it could suppress vaccine uptake. The American Academy of Pediatrics noted that more than 40 high-quality studies across seven countries, involving over 5.6 million people, have investigated this question since 1998 and found no link. The Autism Science Foundation called the new page's content distorted and inconsistent with the best available science, and members of Congress sent a formal letter to Secretary Kennedy objecting to the change.

CLINICAL BOTTOM LINE The underlying science has not changed — only a federal webpage's framing did. More than 40 large, independently conducted studies across seven countries and 5.6+ million children consistently show no causal link between vaccines and autism. Continue counseling families on the established schedule using the existing evidence base, not the revised CDC language.

 

Where the Myth Actually Started

It's worth knowing the origin story, because patients rarely do — and it's a genuinely useful teaching tool in a visit.

In 1998, gastroenterologist Andrew Wakefield published a paper in The Lancet looking at 12 children, eight of whose parents reported autism onset after the MMR vaccine. It wasn't a controlled study — there was no comparison group, and even in its strongest form a case series can only describe, not prove causation. Later investigation found the cases weren't even the consecutive series they were described as; they were selectively chosen. Several co-authors withdrew their names, and the paper was eventually retracted for unethical research practices.

But the damage had a head start. Wakefield was well-credentialed and worked at a respected London hospital, and he actively promoted the paper as proof of causation — a claim the study was never capable of supporting. The story also landed on fertile ground for reasons that have nothing to do with data: autism symptoms often become apparent right around the age children receive several vaccines, autism diagnoses have been rising, and its causes remain incompletely understood. Parents watching a child regress naturally look for an explanation, and a shared, recent event — the vaccine — was an obvious candidate, even though correlation in timing is not causation.

As the MMR-specific claim was studied and consistently disproven, the hypothesis migrated — first to thimerosal (a preservative that was never in MMR but was used in some other vaccines), then to the total number of vaccines given in early childhood. Each hypothesis was tested. None held up. Today there are more than a dozen large, independently conducted, population-based studies across different countries and methods, and all of them find no relationship between vaccination — MMR, thimerosal, or vaccine quantity — and autism.

NUANCE Older Institute of Medicine (2012) and AHRQ (2014, 2021) reviews used cautious language — “insufficient evidence to accept or reject” — for a few specific vaccine-condition pairs. That phrasing is sometimes selectively quoted to suggest ongoing scientific doubt. In context, those reviews predate much of the largest and most rigorous cohort evidence (including large Scandinavian registry studies) and were applying a deliberately conservative evidentiary standard, not reporting a genuine 50/50 open question.

 

A Case From Practice: The “Amish Don't Get Autism” Claim

CASE FROM PRACTICE In testimony before the Pennsylvania Senate in June 2023, a tech entrepreneur turned COVID-19 conspiracy theorist told lawmakers that Amish children don't develop autism because the community largely avoids vaccination — and suggested the government was suppressing data proving these communities are healthier as a result.

This claim is false on every load-bearing point, and it's worth knowing by name because it keeps resurfacing in high-visibility settings:

●        No study has ever found a vaccine-autism link, in Amish communities or otherwise — and the original Wakefield paper was retracted for unethical research practices, not just weak methodology.

●        Amish children do get autism. A preliminary study found Amish children are diagnosed at roughly a third of the national rate — lower, but very much present, not zero. That gap is plausibly explained by underdiagnosis (Amish children aren't in public schools where developmental delays are often first flagged) and differences in how Amish parents report behavior, not by vaccination status.

●        Many Amish children are vaccinated. Amish vaccination rates are lower than the general public's, but far from zero — most families vaccinate at least partially, and the community is not the uniform “unvaccinated population” the myth assumes.

The reason this example is useful in practice isn't just the facts — it's the shape of the argument. It relies on treating a lower reported rate as though it were a true zero, and treating an under-studied population as a clean natural experiment when it isn't one. That's a pattern worth training your ear to catch, whether it shows up as “Amish kids” or the next community someone points to.

What to Tell Families

You don't need to relitigate the CDC's website with an anxious parent in a 15-minute visit. A few grounding points tend to work well:

●        Lead with the weight of evidence, not a single study: “This has been studied more than almost anything else in medicine — dozens of large studies, millions of children, multiple countries — and they consistently find no link.”

●        Validate the concern without validating the claim. Many parents raising this aren't anti-vaccine; they're scared and have seen conflicting messages from federal sources. Acknowledge the confusion is reasonable given the news coverage, without conceding the science is actually unsettled.

●        Be transparent that a federal webpage changed. It's fine to say plainly that the CDC's own language shifted for political reasons this fall, that the change was criticized by major medical and scientific organizations, and that it doesn't reflect a change in the underlying research.

●        Know your professional organizations' positions. AAP and most major specialty societies have reaffirmed the no-link position since the CDC change. Pointing families to a professional body they may already trust can land better than a debate about a government website.

Board Prep: Quick Review

BOARD PREP Q: What was the key methodological flaw in the 1998 Wakefield study? A: No control group; a small, non-consecutive (cherry-picked) case series that could describe an association but never establish causation. Q: Name three hypotheses that have each been tested and disproven in the vaccine-autism literature. A: MMR vaccination, thimerosal exposure, and total number/timing of childhood vaccines. Q: How would you counter the claim that Amish children don't get autism because they're unvaccinated? A: Amish children are diagnosed with autism (at roughly a third of the national rate, likely reflecting underdiagnosis/underreporting rather than true absence), and many Amish families are at least partially vaccinated — the premise that the community is an unvaccinated, autism-free control group is false on both counts.

The Bottom Line

Vaccines remain one of the most thoroughly studied interventions in medicine, and the evidence on autism specifically is deep and consistent: no causal link, across vaccine types, across countries, across study designs. A webpage rewrite doesn't change that. What it does change is the environment you're practicing in — expect more questions, expect some patients to arrive already primed by headlines, and expect that your calm, evidence-grounded explanation will matter more than ever.

References

1. American Council on Science and Health. “Vaccines, Autism, and a CDC That Blinked.” December 4, 2025. acsh.org.

2. ABC News. “CDC webpage says link between autism and vaccines has been ignored, despite several studies finding no evidence.” November 20–21, 2025. abcnews.com.

3. Northeastern Global News. “Experts: CDC Website Shift on Vaccines, Autism Sparks Confusion.” December 2, 2025. news.northeastern.edu.

4. Scientific American. “CDC Vaccine Website Promotes Antiscience Claims of Autism Ties.” November 2025. scientificamerican.com.

5. Reuters (via AOL). “US CDC says claims that vaccines do not cause autism are not evidence-based.” November 2025.

6. Fox News. “CDC quietly changes vaccine and autism stance after years of controversy.” November 20, 2025.

7. Columbia Law School, Sabin Center for Climate Change Law. “CDC Adds Debunked Link Between Autism and Vaccines to Website.” November 2025. climate.law.columbia.edu.

8. U.S. House of Representatives, Rep. Kim Schrier et al. Letter to HHS Secretary Robert F. Kennedy Jr. re: CDC website change. November 21, 2025.

9. National Academies of Sciences, Engineering, and Medicine. Adverse Effects of Pertussis and Rubella Vaccines. Washington, DC: National Academies Press, 1991.

10. National Academies of Sciences, Engineering, and Medicine. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: National Academies Press, 2012.

11. Maglione MA, Gidengil C, Das L, et al. Safety of Vaccines Used for Routine Immunization in the United States. AHRQ Evidence Report/Technology Assessment No. 215, 2014.

12. Gidengil C, Goetz MB, Maglione M, et al. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Agency for Healthcare Research and Quality, 2021.

13. Wakefield AJ, et al. “Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.” The Lancet. 1998. [RETRACTED].

14. Interview transcript, “The Uptake” newsletter — clinical Q&A on the history of vaccine-autism hypotheses (MMR, thimerosal, vaccine quantity) and the 16+ large population-based studies refuting each.

15. Misinformation tracking summary: “Anti-vaccine myth that Amish children don't have autism resurfaces.” Pennsylvania Senate testimony, June 28, 2023.

Authentic Leadership for New Nurse Practitioners: Stretch the Limits of Who You Are!

As a newly minted nurse practitioner, the concept of authentic leadership may seem straightforward: be true to yourself, act in accordance with your values, and maintain consistency between your thoughts, words, and actions. However, a simplistic understanding of authentic leadership can actually hinder your growth and limit your impact in your new role.

Authentic leadership is a journey of self-discovery and continuous learning. It involves not only staying true to your core values but also adapting to new challenges and responsibilities. As you take charge in an unfamiliar role, you may find yourself in situations that test your beliefs and require you to make difficult decisions. In these moments, it's crucial to rely on your values as a compass while remaining open to learning and growth.

One aspect of authentic leadership that new nurse practitioners often struggle with is selling themselves. You may feel uncomfortable promoting your skills and accomplishments, but it's essential to communicate your value to patients, colleagues, and employers. This doesn't mean boasting or exaggerating your abilities; rather, it involves highlighting your unique strengths and contributions with confidence and humility.

Another challenge is processing negative feedback. As a new practitioner, you're bound to make mistakes or encounter criticism from others. Authentic leaders view these experiences as opportunities for growth rather than personal attacks. They seek to understand the perspective of others, take responsibility for their actions, and use feedback to improve their practice.

Maintaining a playful frame of mind is also key to authentic leadership. Healthcare can be a serious and stressful field, but approaching challenges with creativity, curiosity, and a sense of humor can help you stay resilient and engaged. Don't be afraid to bring your unique personality and passions to your work, as this can help you connect with patients and colleagues on a deeper level.

Finally, authentic leadership involves learning from diverse role models. Seek out mentors and colleagues who embody the qualities you admire, even if their leadership style differs from your own. By observing and learning from others, you can expand your repertoire of skills and approaches while staying true to your core values. 

Avoid sticking with our personal narrative which can limit and outdate us. The story that resonates with our patient is the only one that matters. Presenting ourselves in the most favorable light to our patients yet setting goals for learning so we don't develop imposter syndrome is important. Learning goals are different from performance goals. As a nurse practitioner, it's essential to set both performance and learning goals to ensure continuous growth and development in your practice. Here are some examples of each:

Performance Goals:

Increase patient satisfaction scores by 10% within the next 6 months by focusing on effective communication and empathy.

Improve documentation accuracy and completeness to 95% within 3 months to ensure better patient care and reduce legal risks.

Learning Goals:

Complete a certification course in a specialty area (e.g., diabetes management, wound care,) within the next 12 months to expand your knowledge and skills.

Attend at least 2 professional conferences or workshops per year to stay current with the latest research, guidelines, and best practices 

Participate in a leadership development program within the next 18 months to enhance your management and communication skills as a healthcare provider.

Remember, these are just examples, and your specific goals should be tailored to your individual needs, interests, and practice setting. Regularly review and adjust your goals as you progress in your career to ensure that you're always striving for growth and improvement as a nurse practitioner.

Authentic leadership is a complex and ongoing process that requires self-awareness, adaptability, and a commitment to growth. As a new nurse practitioner, embrace the challenges and opportunities that come with your role, and trust in your ability to make a positive impact on the lives of your patients and the healthcare system as a whole.

Developing Competent Nurse Practitioners: Applying Miller's Pyramid

 

Nursing education is shifting towards a competency-based model, as outlined in the American Association of Colleges of Nursing's 2021 Essentials. This means that nurse practitioner (NP) students need to demonstrate mastery of key knowledge, skills, and abilities required for practice. How can NP programs effectively assess competency development? One helpful framework highlighted in a recent journal article is Miller's Pyramid of Clinical Competence.

Miller's Pyramid includes four ascending levels of competence: knows, knows how, shows how, and does. This builds from a foundation of core knowledge to being able to demonstrate and apply skills in practice. Here's a quick overview of what each entails:

• Knows: Factual knowledge assessed through multiple-choice questions or written reports
• Knows How: Understanding principles and being able to explain concepts
• Shows How: Demonstrating skill in a simulated setting
• Does: Performing the skill effectively in an actual clinical environment

As students progress through an NP program, they should be evaluated at each tier. Assessment strategies may include written exams, oral questioning, OSCEs with simulated patients, direct observation in clinicals, and student reflective journals. Faculty can determine at what levels additional coaching is needed.

Hampton et al (2024) also discusses adding a fifth peak to the pyramid - the "is" level - which represents embodying the professional identity and core values expected of a practicing NP. This reminds programs that technical skills alone don't suffice; the affective domain is critical too.

In conclusion, Miller's Pyramid provides an excellent rubric for staging the attainment of competencies in NP education. Aligning teaching and evaluation methods to the different levels empowers students with the knowledge, skills, and professional disposition necessary to provide safe, high-quality care. As NP roles continue advancing, so too must preparation to match responsibility. This model offers an evidence-based approach.

Hampton D., Melander, S. Tovar E., Falls C., Makowski A., Ballard Grubbs A., Chitwood. H., Scott, L. (2024). Value of Miller’s Pyramid for Clinical Skills Assessment in the Evaluation of Competency for Nurse Practitioner Students, The Journal for Nurse Practitioners, 20(4), https://doi.org/10.1016/j.nurpra.2024.104952.

Landing Your First NP Job: Essential Interview Questions for Success

Congratulations to all new nurse practitioner graduates! Your journey through NP school has equipped you with the knowledge and skills to embark on a fulfilling career. As you step into the world of job interviews, remember that being well-prepared is key. Not only should you be ready to showcase your abilities, but also to ask insightful questions that will help you understand if a position is the right fit for you. Here's a comprehensive guide to help you navigate your first NP job interview.

Crucial Questions to Ask During the Interview

1. Physician-to-NP Ratio: "What is the physician-to-NP ratio at this practice?" This question helps you gauge the level of autonomy you'll have and understand the state's regulations regarding NP practice.
2. Scope of Practice: "Can you describe the scope of practice for NPs in this facility?" It's vital to know the extent of your responsibilities and how they align with your training and expectations.
3. Physician Collaboration and Support: "What is the structure for physician collaboration and support for NPs?" As a new graduate, access to support and mentorship is crucial for your development.
4. Work Schedule: "Do you expect NPs to work a mix of days, evenings, weekends?" Understanding the expected availability is important for maintaining a healthy work-life balance.
5. Call Coverage: "How is call covered? Is there a call back nurse or a triage nurse?" This gives you insight into the support system in place for after-hours patient care.
6. Patient Demographics and Caseload: "What types of patients will I be seeing? What will my patient load look like?" Knowing the patient population and expected volume helps you assess if the role suits your skills and interests.
7. Electronic Medical Records (EMR) System: "What's the EMR system used here?" Familiarity with the system can ease your transition; if it's new to you, inquire about training opportunities.
8. Role within the Care Team: "How is the NP role incorporated into the care team?" Understanding your role in the larger workflow is essential for effective collaboration.
9. Community Engagement and Marketing: "How will the community know I am available to see patients?" This question addresses the clinic's efforts in marketing and community outreach, which can impact your patient base.
10. Professional Development: "Are there opportunities for continuing education and professional development?" This shows your commitment to growth and learning, a trait highly valued in healthcare.
11. Career Advancement: "What opportunities are there for career advancement?" Even as a new NP, it's important to consider long-term prospects within the organization.
12. Mission and Work Culture: "What is the mission of the clinic? How would you describe the work culture here?" These questions help you determine if the clinic's values and environment align with your own.
13. Performance Evaluation: "How is performance typically evaluated for NPs in this role?" Understanding how your performance will be assessed provides clarity on expectations and benchmarks.

Questions You Should Be Prepared to Answer

1. Interest in the Position: "Why are you interested in this role and our organization/clinic?" Articulate your motivation and show that you've researched their practice.
2. Clinical Experience: "Can you describe your clinical experiences during your NP program?" Discuss your rotations, patient types managed, and any notable cases.
3. Patient Care Philosophy: "What is your philosophy of patient care?" Share your approach and how it aligns with the facility's values.
4. Handling Stressful Situations: "How do you handle high-pressure situations?" Demonstrate your ability to remain composed and effective under stress.
5. Teamwork and Collaboration: "Can you give an example of effective teamwork?" Highlight your collaborative skills and experiences working with diverse healthcare teams.
6. Adapting to Change: "How do you adapt to changes in healthcare practices or protocols?" Show your flexibility and openness to new methods or technologies.
7. Career Goals: "Where do you see yourself in five years?" Discuss realistic career progression goals that align with the role.
8. Dealing with Difficult Patients: "Can you share an experience with a difficult patient or situation?" This assesses your interpersonal skills and problem-solving abilities.
9. Overall Preparedness: "Do you have any questions for me about this position?" Come with a list of thoughtful questions that demonstrate your interest and understanding of the role.

Preparing for these questions will not only help you make a strong impression but also ensure you find a position that aligns with your career goals and values. Remember, an interview is a two-way street; it's as much about assessing if the role is right for you as it is about the employer evaluating your fit. Be honest, be yourself, and most importantly, be prepared. Wishing you the best of luck in your interviews! 🍀👩‍⚕️🏥